Skip to content
DataLookout
Menu

MENTORNCT07410052

Microbiome-Targeted Enhancement of Neurocognition With Probiotics-Riboflavin Combination

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 5 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 19 words Show 5 more changesShow less
    • Trial status changed: Not Yet Recruiting → Active, Not Recruiting
    • Primary completion pushed from Jul 15, 2027 to Dec 15, 2027
    • Study completion pushed from Aug 15, 2027 to Feb 15, 2028
    • Study sites: 0 to 1
    • Secondary endpoints: details revised at 2 of 4 entries
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Montreal Cognitive Assesment scores
Timeframe: Change from baseline The Montreal Cognitive Assessment (MoCA) score at 12 weeks

Secondary (4)

Mini-Mental State Examination Score
Pittsburgh Sleep Quality Index (PSQI)
Brain oxygen saturation
Grip strength

Arms and interventions

Experimental 1Experimental

2 capsules of probiotic and riboflavin cellulose per day

Experimental 2Placebo comparator

2 capsules of microcrystaline cellulose per day

Dietary supplements: Experimental 1, Experimental 2

Sites

1 site in 1 country

  • Center for Health SciencesBelgrade, Serbia